Literature DB >> 27930754

Novel Precision Medicine Trial Designs: Umbrellas and Baskets.

Howard Jack West.   

Abstract

Mesh：

Year:  2017        PMID： 27930754     DOI： 10.1001/jamaoncol.2016.5299

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  17 in total

1.  Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis.

Authors:  Karolina Strzebonska; Mateusz Blukacz; Mateusz T Wasylewski; Maciej Polak; Bishal Gyawali; Marcin Waligora
Journal:  BMC Med       Date:  2022-07-08       Impact factor: 11.150

2.  Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies.

Authors:  Fang-Shu Ou; Ming-Wen An; Amy S Ruppert; Sumithra J Mandrekar
Journal:  JCO Precis Oncol       Date:  2019-10-24

3.  MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach.

Authors:  Hans-Joachim Schmoll; Dirk Arnold; Aimery de Gramont; Michel Ducreux; Axel Grothey; Peter J O'Dwyer; Eric Van Cutsem; Frank Hermann; Ivan Bosanac; Belguendouz Bendahmane; Christoph Mancao; Josep Tabernero
Journal:  J Cancer Res Clin Oncol       Date:  2018-04-11       Impact factor: 4.553

4.  Guidelines for clinical evaluation of anti-cancer drugs.

Authors:  Hironobu Minami; Naomi Kiyota; Shiro Kimbara; Yuichi Ando; Tomoya Shimokata; Atsushi Ohtsu; Nozomu Fuse; Yasutoshi Kuboki; Toshio Shimizu; Noboru Yamamoto; Kazuto Nishio; Yutaka Kawakami; Shin-Ichi Nihira; Kazuhiro Sase; Takahiro Nonaka; Hideaki Takahashi; Yukiko Komori; Koshin Kiyohara
Journal:  Cancer Sci       Date:  2021-06-08       Impact factor: 6.716

5.  Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth.

Authors:  Cristina Nuevo-Tapioles; Fulvio Santacatterina; Konstantinos Stamatakis; Cristina Núñez de Arenas; Marta Gómez de Cedrón; Laura Formentini; José M Cuezva
Journal:  Nat Commun       Date:  2020-07-17       Impact factor: 14.919

6.  Precision oncology: lessons learned and challenges for the future.

Authors:  Hsih-Te Yang; Ronak H Shah; David Tegay; Kenan Onel
Journal:  Cancer Manag Res       Date:  2019-08-07       Impact factor: 3.989

7.  Umbrella and basket trials in oncology: ethical challenges.

Authors:  Karolina Strzebonska; Marcin Waligora
Journal:  BMC Med Ethics       Date:  2019-08-23       Impact factor: 2.652

8.  Accomplishing an adaptive clinical trial for cancer: Valuation practices and care work across the laboratory and the clinic.

Authors:  Julia Swallow; Anne Kerr; Choon Key Chekar; Sarah Cunningham-Burley
Journal:  Soc Sci Med       Date:  2020-03-24       Impact factor: 4.634

9.  Everolimus-containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study.

Authors:  Zhanhong Chen; Yabing Zheng; Wenming Cao; Yuzi Zhang; Zhengyi Zhao; Guoqiang Wang; Jing Zhao; Shangli Cai; Xiying Shao; Jian Huang; Weiwu Ye; Yuan Huang; Wei Li; Xiang Huang; Hao Wu; Xiaojia Wang; Yongmei Yin
Journal:  Cancer Med       Date:  2019-08-06       Impact factor: 4.452

Review 10.  Precision Oncology-The Quest for Evidence.

Authors:  Theodoros G Soldatos; Sajo Kaduthanam; David B Jackson
Journal:  J Pers Med       Date:  2019-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.